Baker Hughes–Chart Merger Faces Regulatory Hurdles, Integration Risks and Market Volatility Ahead of 2025 Close
Baker Hughes Company (BKR) has disclosed a new risk, in the Corporate Activity and Growth category.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The analyst notes that Baker Hughes Company’s proposed July 28, 2025 merger with Chart introduces significant business, regulatory, and reputational uncertainty. Completion of the transaction depends on the timing, terms, and potential conditions of governmental and antitrust approvals, as well as the resolution of any legal challenges and the risk of termination fees if the deal fails to close. Even if approved, the transaction could disrupt ongoing operations, strain management attention, and expose Baker Hughes to integration risks, higher-than-expected costs, and possible dis-synergies that erode anticipated EBITDA, revenue growth, and shareholder returns. Furthermore, the announcement and potential consummation of the merger may affect relationships with employees, suppliers, and competitors, pressure credit ratings, and increase share price volatility for both Baker Hughes and Chart amid broader macroeconomic and market headwinds.
The average BKR stock price target is $61.54, implying 4.45% upside potential.
To learn more about Baker Hughes Company’s risk factors, click here.
